Trial intelligence / Profile preview

Citicoline for Marijuana Dependence

NCT00158249Phase 2Completed

Sponsor
McLean Hospital
Start
Sep 2009
Primary completion
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of citicoline in cannabis use disorder (CUD), sponsored by McLean Hospital. Started Sep 2009; status: completed.

02

Drugs

citicoline
03

Conditions

cannabis use disorder (CUD)

Beyond the preview

Go deeper on NCT00158249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00158249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call